Publication:
QT prolongation risk with antiemetics during COVID 19 treatment

Simple item page
dc.contributor.authorSANCAR, MESUT
dc.contributor.authorsAksoy, Nilay; Sancar, Mesut
dc.date.accessioned2022-03-11T23:50:37Z
dc.date.available2022-03-11T23:50:37Z
dc.date.issued2021-05
dc.identifier.doi10.1111/ijcp.14041
dc.identifier.eissn1742-1241
dc.identifier.issn1368-5031
dc.identifier.pubmed33887871
dc.identifier.urihttps://hdl.handle.net/11424/223123
dc.identifier.wosWOS:000644132400065
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofINTERNATIONAL JOURNAL OF CLINICAL PRACTICE
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleQT prolongation risk with antiemetics during COVID 19 treatment
dc.typeother
dc.type.subletter
dspace.entity.typePublication
local.avesis.id2659df56-0ac8-4cd1-8a1a-33b3b4fd7173
local.import.packageSS6
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atPUBMED
local.journal.articlenumbere14041
local.journal.numberofpages2
oaire.citation.issue5
oaire.citation.titleINTERNATIONAL JOURNAL OF CLINICAL PRACTICE
oaire.citation.volume75
relation.isAuthorOfPublication87a6fc65-406c-478f-bc6d-ffaaaf1f7b31
relation.isAuthorOfPublication.latestForDiscovery87a6fc65-406c-478f-bc6d-ffaaaf1f7b31

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Aksoy and Sancar - 2021 - QT prolongation risk with antiemetics during COVID.pdf
Size:
219.04 KB
Format:
Adobe Portable Document Format
Download

Collections

Research Outputs